Nicholas Hanna to Treatment Outcome
This is a "connection" page, showing publications Nicholas Hanna has written about Treatment Outcome.
Connection Strength
0.458
-
Low-dose protamine to facilitate earlier sheath removal from the femoral artery after peripheral endovascular intervention. J Interv Cardiol. 2011 Jun; 24(3):278-84.
Score: 0.057
-
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry). Am J Cardiol. 2010 Aug 15; 106(4):504-10.
Score: 0.054
-
Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes. Circ Cardiovasc Interv. 2023 May; 16(5):e012655.
Score: 0.033
-
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study. EuroIntervention. 2022 Aug 05; 18(5):e407-e416.
Score: 0.031
-
Balloon-Expandable Valve Geometry After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Bicuspid Versus Tricuspid Aortic Stenosis. Cardiovasc Revasc Med. 2021 12; 33:7-12.
Score: 0.028
-
Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trial. Am Heart J. 2021 07; 237:25-33.
Score: 0.028
-
Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk Patients. Circ Cardiovasc Interv. 2021 01; 14(1):e009983.
Score: 0.028
-
Anatomical Characteristics Associated With Hypoattenuated Leaflet Thickening in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2021 06; 27:1-6.
Score: 0.027
-
Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients. JACC Cardiovasc Interv. 2020 03 23; 13(6):726-735.
Score: 0.026
-
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis. JACC Cardiovasc Interv. 2020 05 11; 13(9):1019-1027.
Score: 0.026
-
Hemodynamics and Subclinical Leaflet Thrombosis in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement. Circ Cardiovasc Imaging. 2019 12; 12(12):e009608.
Score: 0.026
-
TAVR in Low-Risk Patients: 1-Year Results From the LRT Trial. JACC Cardiovasc Interv. 2019 05 27; 12(10):901-907.
Score: 0.025
-
Endovascular recanalization of central venous access to allow for pacemaker implantation or upgrade. Cardiovasc Revasc Med. 2012 Jul-Aug; 13(4):215-8.
Score: 0.015
-
Does on- versus off-hours presentation impact in-hospital outcomes of ST-segment elevation myocardial infarction patients transferred to a tertiary care center? Catheter Cardiovasc Interv. 2010 Oct 01; 76(4):484-90.
Score: 0.014
-
A novel percutaneous coronary intervention risk score to predict one-year mortality. Am J Cardiol. 2010 Sep 01; 106(5):641-5.
Score: 0.014
-
Utility of radiologic review for noncardiac findings on multislice computed tomography in patients with severe aortic stenosis evaluated for transcatheter aortic valve implantation. Am J Cardiol. 2010 May 15; 105(10):1461-4.
Score: 0.013
-
A further word of caution before using the internal mammary artery for coronary revascularization in patients with severe peripheral vascular disease! Catheter Cardiovasc Interv. 2010 Feb 01; 75(2):195-201.
Score: 0.013